Lower limb arterial thrombosis followed by sub-massive pulmonary thromboembolism after Sinopharm BBIBP-CorV COVID-19 vaccination
Abstract
Keywords
Full Text:
PDFReferences
Quazi S. Vaccine in response to COVID-19: Recent developments, challenges, and a way out. BBRJ. 2021; 5(2):105-109. doi 10.4103/bbrj.bbrj_166_20.
Franchini M, Liumbruno GM, Pezzo M. COVID‐19 Vaccine‐associated Immune Thrombosis and Thrombocytopenia (VITT): diagnostic and therapeutic recommendations for a new syndrome. Eur J Haematol. 2021; 107(2): 173-180. doi: 10.1111/ejh.13665.
Aleem A, Nadeem AJ. Coronavirus (COVID-19) Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 34033367.
Rahimi FS, Afaghi S, Esmaeili Tarki F, Goudarzi K, Malekpour Alamdari N. Viral Outbreaks of SARS-CoV1, SARS-CoV2, MERS-CoV, Influenza H1N1, and Ebola in 21st Century; A Comparative Review of the Pathogenesis and Clinical Characteristics. Sch Med Stud J. 2020;2(3):1-8.
Basiri, N, M. Koushki, Study of Vaccine Production Abroad and Scientific and Research Challenges of COVID-19 Vaccine Production in Iran. Annals of RSCB. 2021;25(4):17249-56.
Khankeh HR, Farrokhi M, Khanjani MS, et al. The Barriers, Challenges, and Strategies of COVID-19 (SARS-CoV-2) Vaccine Acceptance: A Concurrent Mixed-Method Study in Tehran City, Iran. Vaccines (Basel). 2021; 9(11):1248. doi: 10.3390/vaccines9111248.
Sofonea MT, Roquebert B, Foulongne V, et al. Analyzing and Modeling the Spread of SARS-CoV-2 Omicron Lineages BA.1 and BA.2, France, September 2021-February 2022. Emerg Infect Dis. 2022; 28(7):1355-1365. doi: 10.3201/eid2807.220033.
Karimi A, Hashemian SMR. Cytokine storm in COVID-19 and the treatment simulacrum. BBRJ. 2020; 4(5):41-48. doi: 10.4103/bbrj.bbrj_128_20.
Garg K, Talwar D, Mahajan SN et al. A review on COVID-19 vaccinations. BBRJ. 2022; 6(1): 50-53. doi: 10.4103/bbrj.bbrj_128_20.
McDonnell T, hornber M, Cooksley T, Jain S, McGlynn S. Left inferior ophthalmic vein thrombosis due to VITT: a case report. QJM. 2022; 114(11):810-811. doi: 10.1093/qjmed/hcab124.
Devi K, Ali N, Nasir N, Mahmood SF. VITT with inactivated SARS-CoV-2 vaccine–index case. Hum Vaccin Immunother. 2022; 18(1):2036556. doi: 10.1080/21645515.2022.2036556.
Hosseinzadeh R, Barary M, Mehdinezhad H, Sio TT, Langer F, Khosravi S. Thrombotic thrombocytopenia After Sinopharm BBIBP‐CorV COVID‐19 vaccination. Res Pract Thromb Haemost. 2022; 6(4):e12750. doi: 10.1002/rth2.12750.
Mahla E, Tantry US, Schoerghuber M, Gurbel PA. Platelet function testing in patients on antiplatelet therapy before cardiac surgery. Anesthesiology. 2020; 133(6):1263-1276. doi: 10.1097/ALN.0000000000003541.
Bérezné A, Bougon D, Blanc-Jouvan F, et al. Deterioration of vaccine‐induced immune thrombotic thrombocytopenia treated by heparin and platelet transfusion: Insight from functional cytometry and serotonin release assay. Res Pract Thromb Haemost. 2021; 5(6):e12572. doi: 10.1002/rth2.12572.
Lentz SR. Cooling down VITT with IVIG. Blood. 2021; 138(11):921-922. doi: 10.1182/blood.2021012819.
DOI: http://dx.doi.org/10.22551/2022.37.0904.10222
Copyright (c) 2022 Hamidreza Zaheri, Arda Kiani, Siamak Afaghi, Fatemehsadat Rahimi, Mohammadhossein Banitorfi, Amirmohammad Kazemzadeh Norozi, Samaneh Hashemi, Atefeh Abedini
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
ISSN: 2360-6975